Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 458

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study

Open access
Schmidt, Matthieu, Hajage, David, Lebreton, Guillaume, Monsel, Antoine, Voiriot, Guillaume, Levy, David, Baron, Elodie, Beurton, Alexandra, Chommeloux, Juliette, Meng, Paris, Nemlaghi, Safaa, Bay, Pierre, Leprince, Pascal, Demoule, Alexandre, Guidet, Bertrand, Constantin, Jean Michel, Fartoukh, Muriel, Dres, Martin, Combes, Alain, Luyt, Charles-Edouard, Hekimian, Guillaume, Brechot, Nicolas, Pineton de Chambrun, Marc, Desnos, Cyrielle, Arzoine, Jeremy, Guerin, Emmanuelle, Schoell, Thibaut, Demondion, Pierre, Juvin, Charles, Nardonne, Nathalie, Marin, Sofica, D'Alessandro, Cossimo, Nguyen, Bao-Long, Quemeneur, Cyril, James, Arthur, Assefi, Mona, Lepere, Victoria, Savary, Guillaume, Gibelin, Aude, Turpin, Matthieu, Elabbadi, Alexandre, Berti, Enora, Vezinet, Corinne, Bonvallot, Harold, Delmotte, Pierre-Romain, De Sarcus, Martin, Du Fayet De La Tour, Charlotte, Abbas, Samia, Maury, Eric, Baudel, Jean-Luc, Lavillegrand, Jean-Remi, Ait Oufella, Hafid, Abdelkrim, Abdelmalek, Urbina, Thomas, Virolle, Sara, Deleris, Robin, Bonny, Vincent, Le Marec, Julien, Mayaux, Julien, Morawiec, Elise·2020·The Lancet Respiratory Medicine

Abstract

Background Patients with COVID-19 who develop severe acute respiratory distress syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and death. The efficacy of extracorporeal membrane oxygenation (ECMO) for patients with severe ARDS in the context of COVID-19 is unclear. We aimed to establish the clinical characteristics and outcomes of patients with respiratory failure and COVID-19 treated with ECMO. Methods This retrospective cohort study was done in the Paris–Sorbonne University Hospital Network, comprising five intensive care units (ICUs) and included patients who received ECMO for COVID-19 associated ARDS. Patient demographics and daily pre-ECMO and on-ECMO data and outcomes were collected. Possible outcomes over time were categorised into four different states (states 1–4): on ECMO, in the ICU and weaned off ECMO, alive and out of ICU, or death. Daily probabilities of occupation in each state and of transitions between these states until day 90 post-ECMO onset were estimated with use of a multi-state Cox model stratified for each possible transition. Follow-up was right-censored on July 10, 2020. Findings From March 8 to May 2, 2020, 492 patients with COVID-19 were treated in our ICUs. Complete day-60 follow-up was available for 83 patients (median age 49 [IQR 41–56] years and 61 [73%] men) who received ECMO. Pre-ECMO, 78 (94%) patients had been prone-positioned; their median driving pressure was 18 (IQR 16–21) cm H2O and PaO2/FiO2 was 60 (54–68) mm Hg. At 60 days post-ECMO initiation, the estimated probabilities of occupation in each state were 6% (95% CI 3–14) for state 1, 18% (11–28) for state 2, 45% (35–56) for state 3, and 31% (22–42) for state 4. 35 (42%) patients had major bleeding and four (5%) had a haemorrhagic stroke. 30 patients died. Interpretation The estimated 60-day survival of ECMO-rescued patients with COVID-19 was similar to that of studies published in the past 2 years on ECMO for severe ARDS. If another COVID-19 outbreak occurs, ECMO should be considered for patients developing refractory respiratory failure despite optimised care. Funding None.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(20)30328-3

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 458

Metadata

Authors
Schmidt, M., Hajage, D., Lebreton, G., Monsel, A., Voiriot, G., Levy, D., Baron, E., Beurton, A., Chommeloux, J., Meng, P., Nemlaghi, S., Bay, P., Leprince, P., Demoule, A., Guidet, B., Constantin, J. M., Fartoukh, M., Dres, M., Combes, A., Luyt, C.-E., Hekimian, G., Brechot, N., Pineton de Chambrun, M., Desnos, C., Arzoine, J., Guerin, E., Schoell, T., Demondion, P., Juvin, C., Nardonne, N., Marin, S., D'Alessandro, C., Nguyen, B.-L., Quemeneur, C., James, A., Assefi, M., Lepere, V., Savary, G., Gibelin, A., Turpin, M., Elabbadi, A., Berti, E., Vezinet, C., Bonvallot, H., Delmotte, P.-R., De Sarcus, M., Du Fayet De La Tour, C., Abbas, S., Maury, E., Baudel, J.-L., Lavillegrand, J.-R., Ait Oufella, H., Abdelkrim, A., Urbina, T., Virolle, S., Deleris, R., Bonny, V., Le Marec, J., Mayaux, J., & Morawiec, E.
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2020-11
Volume
8
Issue
11
Pages
1121-1131
ISSN
2213-2600 (ISSN-L)
OpenAlex
W3048382678
Cited by
458
References
37
FWCI
27.43
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. https://app.cochat.ai/papers/10.1016/s2213-2600(20)30328-3
The paper
Schmidt, M., Hajage, D., Lebreton, G., Monsel, A., Voiriot, G., Levy, D., Baron, E., Beurton, A., Chommeloux, J., Meng, P., Nemlaghi, S., Bay, P., Leprince, P., Demoule, A., Guidet, B., Constantin, J. M., Fartoukh, M., Dres, M., Combes, A., . . . Morawiec, E. (2020). Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(20)30328-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.